2022
DOI: 10.1016/j.ctrv.2022.102353
|View full text |Cite
|
Sign up to set email alerts
|

The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
9
0
4

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 89 publications
0
9
0
4
Order By: Relevance
“…Adherence to clinical practice guideline (CPG) recommendations for cancer treatment has been associated with improved patient survival outcomes. This has previously been demonstrated across various cancers including sarcoma, 1 multiple myeloma 2 and cancers of the breast, 3–6 cervix, 7 lung, 8 head and neck, 9 and colon 10 . Despite this, wide variation in practice patterns persist across cancer streams internationally, with adherence rates ranging from 54% to 77% in breast cancer, 11,12 35% to 56% in lung cancer, 13–16 42% to 54% in cervical cancer, 7 22% to 85% in non‐muscle invasive bladder cancer, 17,18 24% to 85% in ovarian cancer, 19,20 67% to 81% in prostate cancer, 21,22 and 36% to 96% in colon cancer 23,24 .…”
Section: Introductionmentioning
confidence: 93%
See 4 more Smart Citations
“…Adherence to clinical practice guideline (CPG) recommendations for cancer treatment has been associated with improved patient survival outcomes. This has previously been demonstrated across various cancers including sarcoma, 1 multiple myeloma 2 and cancers of the breast, 3–6 cervix, 7 lung, 8 head and neck, 9 and colon 10 . Despite this, wide variation in practice patterns persist across cancer streams internationally, with adherence rates ranging from 54% to 77% in breast cancer, 11,12 35% to 56% in lung cancer, 13–16 42% to 54% in cervical cancer, 7 22% to 85% in non‐muscle invasive bladder cancer, 17,18 24% to 85% in ovarian cancer, 19,20 67% to 81% in prostate cancer, 21,22 and 36% to 96% in colon cancer 23,24 .…”
Section: Introductionmentioning
confidence: 93%
“…Patient and health specific factors, such as older patient age and comorbidities, also influence adherence to CPGs across a variety of cancers, 40,41 including cancers of the breast, 3,12 lung, 42 colon, 10 and head and neck 9 . Older and less healthy patients are underrepresented in clinical trials, which may reduce clinician confidence in the evidence underpinning some CPG recommendations and contribute to low rates of adherence 3,38 . Eastern Cooperative Oncology Group (ECOG) Performance status, 12,14 cancer stage, 7,9,16 patient race, 13,43 and socioeconomic status (SES) 43 have also been associated with low rates of CPG adherence within specific cancer groups.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations